The	O
efficacy	O
of	O
human	B:C0086418
placenta	O
-	O
derived	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
on	O
radiation	O
enteropathy	I:C0341275
along	O
with	O
proteomic	O
biomarkers	O
predicting	O
a	O
favorable	O
response	I:C4054987
.	O

The	O
efficacy	O
of	O
human	O
placenta	B:C0032043
-	O
derived	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
on	O
radiation	O
enteropathy	I:C0341275
along	O
with	O
proteomic	O
biomarkers	O
predicting	O
a	O
favorable	O
response	I:C4054987
.	O

The	O
efficacy	O
of	O
human	O
placenta	O
-	O
derived	O
mesenchymal	B:C1257975
stem	I:C1257975
cells	I:C1257975
on	O
radiation	O
enteropathy	I:C0341275
along	O
with	O
proteomic	O
biomarkers	O
predicting	O
a	O
favorable	O
response	I:C4054987
.	O

The	O
efficacy	O
of	O
human	O
placenta	O
-	O
derived	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
on	O
radiation	B:C0341275
enteropathy	I:C0341275
along	O
with	O
proteomic	O
biomarkers	O
predicting	O
a	O
favorable	O
response	I:C4054987
.	O

The	O
efficacy	O
of	O
human	O
placenta	O
-	O
derived	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
on	O
radiation	O
enteropathy	I:C0341275
along	O
with	O
proteomic	B:C0751973
biomarkers	O
predicting	O
a	O
favorable	O
response	I:C4054987
.	O

The	O
efficacy	O
of	O
human	O
placenta	O
-	O
derived	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
on	O
radiation	O
enteropathy	I:C0341275
along	O
with	O
proteomic	O
biomarkers	B:C0005516
predicting	O
a	O
favorable	O
response	I:C4054987
.	O

The	O
efficacy	O
of	O
human	O
placenta	O
-	O
derived	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
on	O
radiation	O
enteropathy	I:C0341275
along	O
with	O
proteomic	O
biomarkers	O
predicting	O
a	O
favorable	B:C4054987
response	I:C4054987
.	O

Radiation	B:C0341275
enteropathy	I:C0341275
is	O
a	O
common	O
complication	O
in	O
patients	O
with	O
abdominopelvic	O
cancer	I:C0153662
,	O
but	O
no	O
treatment	O
has	O
yet	O
been	O
established	O
.	O

Radiation	O
enteropathy	I:C0341275
is	O
a	O
common	O
complication	B:C0009566
in	O
patients	O
with	O
abdominopelvic	O
cancer	I:C0153662
,	O
but	O
no	O
treatment	O
has	O
yet	O
been	O
established	O
.	O

Radiation	O
enteropathy	I:C0341275
is	O
a	O
common	O
complication	O
in	O
patients	O
with	O
abdominopelvic	B:C0153662
cancer	I:C0153662
,	O
but	O
no	O
treatment	O
has	O
yet	O
been	O
established	O
.	O

Radiation	O
enteropathy	I:C0341275
is	O
a	O
common	O
complication	O
in	O
patients	O
with	O
abdominopelvic	O
cancer	I:C0153662
,	O
but	O
no	O
treatment	B:C0087111
has	O
yet	O
been	O
established	O
.	O

Stem	O
cell	O
therapy	O
may	O
be	O
a	O
viable	O
therapeutic	B:C0087111
option	O
because	O
intestinal	O
stem	O
cells	I:C0038250
are	O
highly	O
vulnerable	O
to	O
ionizing	O
radiation	O
(	O
IR	O
)	O
and	O
stem	O
cell	I:C0038250
loss	O
explains	O
its	O
intractability	O
to	O
general	O
treatment	O
.	O

Stem	O
cell	O
therapy	O
may	O
be	O
a	O
viable	O
therapeutic	O
option	O
because	O
intestinal	B:C0021853
stem	O
cells	I:C0038250
are	O
highly	O
vulnerable	O
to	O
ionizing	O
radiation	O
(	O
IR	O
)	O
and	O
stem	O
cell	I:C0038250
loss	O
explains	O
its	O
intractability	O
to	O
general	O
treatment	O
.	O

Stem	O
cell	O
therapy	O
may	O
be	O
a	O
viable	O
therapeutic	O
option	O
because	O
intestinal	O
stem	B:C0038250
cells	I:C0038250
are	O
highly	O
vulnerable	O
to	O
ionizing	O
radiation	O
(	O
IR	O
)	O
and	O
stem	O
cell	I:C0038250
loss	O
explains	O
its	O
intractability	O
to	O
general	O
treatment	O
.	O

Stem	O
cell	O
therapy	O
may	O
be	O
a	O
viable	O
therapeutic	O
option	O
because	O
intestinal	O
stem	O
cells	I:C0038250
are	O
highly	O
vulnerable	O
to	O
ionizing	O
radiation	O
(	O
IR	O
)	O
and	O
stem	B:C0038250
cell	I:C0038250
loss	O
explains	O
its	O
intractability	O
to	O
general	O
treatment	O
.	O

Stem	O
cell	O
therapy	O
may	O
be	O
a	O
viable	O
therapeutic	O
option	O
because	O
intestinal	O
stem	O
cells	I:C0038250
are	O
highly	O
vulnerable	O
to	O
ionizing	O
radiation	O
(	O
IR	O
)	O
and	O
stem	O
cell	I:C0038250
loss	O
explains	O
its	O
intractability	O
to	O
general	O
treatment	B:C0087111
.	O

Here	O
,	O
we	O
investigated	O
either	O
prophylactic	B:C0199176
or	O
therapeutic	O
efficacy	O
of	O
human	O
placenta	O
-	O
derived	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
(	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
)	O
against	O
radiation	O
enteropathy	I:C0341275
and	O
could	O
identify	O
biomarkers	O
predicting	O
a	O
favorable	O
response	I:C4054987
to	O
stem	O
cell	O
therapy	O
.	O

Here	O
,	O
we	O
investigated	O
either	O
prophylactic	O
or	O
therapeutic	B:C0087111
efficacy	O
of	O
human	O
placenta	O
-	O
derived	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
(	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
)	O
against	O
radiation	O
enteropathy	I:C0341275
and	O
could	O
identify	O
biomarkers	O
predicting	O
a	O
favorable	O
response	I:C4054987
to	O
stem	O
cell	O
therapy	O
.	O

Here	O
,	O
we	O
investigated	O
either	O
prophylactic	O
or	O
therapeutic	O
efficacy	O
of	O
human	B:C0086418
placenta	O
-	O
derived	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
(	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
)	O
against	O
radiation	O
enteropathy	I:C0341275
and	O
could	O
identify	O
biomarkers	O
predicting	O
a	O
favorable	O
response	I:C4054987
to	O
stem	O
cell	O
therapy	O
.	O

Here	O
,	O
we	O
investigated	O
either	O
prophylactic	O
or	O
therapeutic	O
efficacy	O
of	O
human	O
placenta	B:C0032043
-	O
derived	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
(	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
)	O
against	O
radiation	O
enteropathy	I:C0341275
and	O
could	O
identify	O
biomarkers	O
predicting	O
a	O
favorable	O
response	I:C4054987
to	O
stem	O
cell	O
therapy	O
.	O

Here	O
,	O
we	O
investigated	O
either	O
prophylactic	O
or	O
therapeutic	O
efficacy	O
of	O
human	O
placenta	O
-	O
derived	O
mesenchymal	B:C1257975
stem	I:C1257975
cells	I:C1257975
(	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
)	O
against	O
radiation	O
enteropathy	I:C0341275
and	O
could	O
identify	O
biomarkers	O
predicting	O
a	O
favorable	O
response	I:C4054987
to	O
stem	O
cell	O
therapy	O
.	O

Here	O
,	O
we	O
investigated	O
either	O
prophylactic	O
or	O
therapeutic	O
efficacy	O
of	O
human	O
placenta	O
-	O
derived	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
(	O
human	B:C1257975
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
)	O
against	O
radiation	O
enteropathy	I:C0341275
and	O
could	O
identify	O
biomarkers	O
predicting	O
a	O
favorable	O
response	I:C4054987
to	O
stem	O
cell	O
therapy	O
.	O

Here	O
,	O
we	O
investigated	O
either	O
prophylactic	O
or	O
therapeutic	O
efficacy	O
of	O
human	O
placenta	O
-	O
derived	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
(	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
)	O
against	O
radiation	B:C0341275
enteropathy	I:C0341275
and	O
could	O
identify	O
biomarkers	O
predicting	O
a	O
favorable	O
response	I:C4054987
to	O
stem	O
cell	O
therapy	O
.	O

Here	O
,	O
we	O
investigated	O
either	O
prophylactic	O
or	O
therapeutic	O
efficacy	O
of	O
human	O
placenta	O
-	O
derived	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
(	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
)	O
against	O
radiation	O
enteropathy	I:C0341275
and	O
could	O
identify	O
biomarkers	B:C0005516
predicting	O
a	O
favorable	O
response	I:C4054987
to	O
stem	O
cell	O
therapy	O
.	O

Here	O
,	O
we	O
investigated	O
either	O
prophylactic	O
or	O
therapeutic	O
efficacy	O
of	O
human	O
placenta	O
-	O
derived	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
(	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
)	O
against	O
radiation	O
enteropathy	I:C0341275
and	O
could	O
identify	O
biomarkers	O
predicting	O
a	O
favorable	B:C4054987
response	I:C4054987
to	O
stem	O
cell	O
therapy	O
.	O

We	O
challenged	O
a	O
radiation	B:C0341275
-	I:C0341275
induced	I:C0341275
enteropathy	I:C0341275
model	O
with	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
.	O

We	O
challenged	O
a	O
radiation	O
-	I:C0341275
induced	I:C0341275
enteropathy	I:C0341275
model	B:C0012644
with	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
.	O

We	O
challenged	O
a	O
radiation	O
-	I:C0341275
induced	I:C0341275
enteropathy	I:C0341275
model	O
with	O
human	B:C1257975
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
.	O

After	O
sacrifice	O
,	O
we	O
checked	O
the	O
gross	O
anatomy	B:C0700276
of	O
small	O
intestine	I:C0021852
,	O
histology	O
gross	O
,	O
and	O
analyzed	O
that	O
,	O
accompanied	O
with	O
molecular	O
changes	O
implicated	O
in	O
this	O
model	O
.	O

After	O
sacrifice	O
,	O
we	O
checked	O
the	O
gross	O
anatomy	O
of	O
small	B:C0021852
intestine	I:C0021852
,	O
histology	O
gross	O
,	O
and	O
analyzed	O
that	O
,	O
accompanied	O
with	O
molecular	O
changes	O
implicated	O
in	O
this	O
model	O
.	O

After	O
sacrifice	O
,	O
we	O
checked	O
the	O
gross	O
anatomy	O
of	O
small	O
intestine	I:C0021852
,	O
histology	O
gross	O
,	O
and	O
analyzed	B:C0936012
that	O
,	O
accompanied	O
with	O
molecular	O
changes	O
implicated	O
in	O
this	O
model	O
.	O

After	O
sacrifice	O
,	O
we	O
checked	O
the	O
gross	O
anatomy	O
of	O
small	O
intestine	I:C0021852
,	O
histology	O
gross	O
,	O
and	O
analyzed	O
that	O
,	O
accompanied	O
with	O
molecular	O
changes	O
implicated	O
in	O
this	O
model	B:C0012644
.	O

human	B:C1257975
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
significantly	O
improved	O
the	O
outcome	O
of	O
mice	O
induced	O
with	O
either	O
radiation	O
enteropathy	I:C0341275
or	O
lethal	O
radiation	I:C0039082
syndrome	I:C0039082
(	O
P	O
<	O
0.01	O
)	O
.	O

human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
significantly	O
improved	O
the	O
outcome	O
of	O
mice	B:C0025929
induced	O
with	O
either	O
radiation	O
enteropathy	I:C0341275
or	O
lethal	O
radiation	I:C0039082
syndrome	I:C0039082
(	O
P	O
<	O
0.01	O
)	O
.	O

human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
significantly	O
improved	O
the	O
outcome	O
of	O
mice	O
induced	O
with	O
either	O
radiation	B:C0341275
enteropathy	I:C0341275
or	O
lethal	O
radiation	I:C0039082
syndrome	I:C0039082
(	O
P	O
<	O
0.01	O
)	O
.	O

human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
significantly	O
improved	O
the	O
outcome	O
of	O
mice	O
induced	O
with	O
either	O
radiation	O
enteropathy	I:C0341275
or	O
lethal	B:C0039082
radiation	I:C0039082
syndrome	I:C0039082
(	O
P	O
<	O
0.01	O
)	O
.	O

human	B:C1257975
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
exerted	O
inhibitory	O
actions	O
on	O
inflammatory	O
cytokines	O
,	O
the	O
re-establishment	O
of	O
epithelium	O
homeostasis	O
was	O
completed	O
with	O
increasing	O
endogenous	O
restorative	O
processes	I:C0031845
as	O
assessed	O
with	O
increased	O
levels	O
of	O
proliferative	O
markers	O
in	O
the	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
group	O
,	O
and	O
a	O
significant	O
inhibition	O
of	O
IR	O
-	O
induced	O
apoptosis	O
.	O

human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
exerted	O
inhibitory	O
actions	O
on	O
inflammatory	O
cytokines	B:C0079189
,	O
the	O
re-establishment	O
of	O
epithelium	O
homeostasis	O
was	O
completed	O
with	O
increasing	O
endogenous	O
restorative	O
processes	I:C0031845
as	O
assessed	O
with	O
increased	O
levels	O
of	O
proliferative	O
markers	O
in	O
the	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
group	O
,	O
and	O
a	O
significant	O
inhibition	O
of	O
IR	O
-	O
induced	O
apoptosis	O
.	O

human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
exerted	O
inhibitory	O
actions	O
on	O
inflammatory	O
cytokines	O
,	O
the	O
re-establishment	O
of	O
epithelium	B:C0014609
homeostasis	O
was	O
completed	O
with	O
increasing	O
endogenous	O
restorative	O
processes	I:C0031845
as	O
assessed	O
with	O
increased	O
levels	O
of	O
proliferative	O
markers	O
in	O
the	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
group	O
,	O
and	O
a	O
significant	O
inhibition	O
of	O
IR	O
-	O
induced	O
apoptosis	O
.	O

human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
exerted	O
inhibitory	O
actions	O
on	O
inflammatory	O
cytokines	O
,	O
the	O
re-establishment	O
of	O
epithelium	O
homeostasis	B:C0019868
was	O
completed	O
with	O
increasing	O
endogenous	O
restorative	O
processes	I:C0031845
as	O
assessed	O
with	O
increased	O
levels	O
of	O
proliferative	O
markers	O
in	O
the	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
group	O
,	O
and	O
a	O
significant	O
inhibition	O
of	O
IR	O
-	O
induced	O
apoptosis	O
.	O

human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
exerted	O
inhibitory	O
actions	O
on	O
inflammatory	O
cytokines	O
,	O
the	O
re-establishment	O
of	O
epithelium	O
homeostasis	O
was	O
completed	O
with	O
increasing	O
endogenous	O
restorative	B:C0031845
processes	I:C0031845
as	O
assessed	O
with	O
increased	O
levels	O
of	O
proliferative	O
markers	O
in	O
the	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
group	O
,	O
and	O
a	O
significant	O
inhibition	O
of	O
IR	O
-	O
induced	O
apoptosis	O
.	O

human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
exerted	O
inhibitory	O
actions	O
on	O
inflammatory	O
cytokines	O
,	O
the	O
re-establishment	O
of	O
epithelium	O
homeostasis	O
was	O
completed	O
with	O
increasing	O
endogenous	O
restorative	O
processes	I:C0031845
as	O
assessed	O
with	O
increased	O
levels	O
of	O
proliferative	B:C0334094
markers	O
in	O
the	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
group	O
,	O
and	O
a	O
significant	O
inhibition	O
of	O
IR	O
-	O
induced	O
apoptosis	O
.	O

human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
exerted	O
inhibitory	O
actions	O
on	O
inflammatory	O
cytokines	O
,	O
the	O
re-establishment	O
of	O
epithelium	O
homeostasis	O
was	O
completed	O
with	O
increasing	O
endogenous	O
restorative	O
processes	I:C0031845
as	O
assessed	O
with	O
increased	O
levels	O
of	O
proliferative	O
markers	B:C0005516
in	O
the	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
group	O
,	O
and	O
a	O
significant	O
inhibition	O
of	O
IR	O
-	O
induced	O
apoptosis	O
.	O

human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
exerted	O
inhibitory	O
actions	O
on	O
inflammatory	O
cytokines	O
,	O
the	O
re-establishment	O
of	O
epithelium	O
homeostasis	O
was	O
completed	O
with	O
increasing	O
endogenous	O
restorative	O
processes	I:C0031845
as	O
assessed	O
with	O
increased	O
levels	O
of	O
proliferative	O
markers	O
in	O
the	O
human	B:C1257975
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
group	O
,	O
and	O
a	O
significant	O
inhibition	O
of	O
IR	O
-	O
induced	O
apoptosis	O
.	O

human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
exerted	O
inhibitory	O
actions	O
on	O
inflammatory	O
cytokines	O
,	O
the	O
re-establishment	O
of	O
epithelium	O
homeostasis	O
was	O
completed	O
with	O
increasing	O
endogenous	O
restorative	O
processes	I:C0031845
as	O
assessed	O
with	O
increased	O
levels	O
of	O
proliferative	O
markers	O
in	O
the	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
group	O
,	O
and	O
a	O
significant	O
inhibition	O
of	O
IR	O
-	O
induced	O
apoptosis	B:C0162638
.	O

The	O
preservation	B:C0033085
of	O
cells	O
expressing	O
lysozyme	O
,	O
and	O
Musashi	O
-	I:C0536620
1	I:C0536620
were	O
significantly	O
increased	O
in	O
the	O
hPDSC	O
treatment	O
group	O
.	O

The	O
preservation	O
of	O
cells	B:C0007634
expressing	O
lysozyme	O
,	O
and	O
Musashi	O
-	I:C0536620
1	I:C0536620
were	O
significantly	O
increased	O
in	O
the	O
hPDSC	O
treatment	O
group	O
.	O

The	O
preservation	O
of	O
cells	O
expressing	O
lysozyme	B:C3541379
,	O
and	O
Musashi	O
-	I:C0536620
1	I:C0536620
were	O
significantly	O
increased	O
in	O
the	O
hPDSC	O
treatment	O
group	O
.	O

The	O
preservation	O
of	O
cells	O
expressing	O
lysozyme	O
,	O
and	O
Musashi	B:C0536620
-	I:C0536620
1	I:C0536620
were	O
significantly	O
increased	O
in	O
the	O
hPDSC	O
treatment	O
group	O
.	O

The	O
preservation	O
of	O
cells	O
expressing	O
lysozyme	O
,	O
and	O
Musashi	O
-	I:C0536620
1	I:C0536620
were	O
significantly	O
increased	O
in	O
the	O
hPDSC	B:C1257975
treatment	O
group	O
.	O

The	O
preservation	O
of	O
cells	O
expressing	O
lysozyme	O
,	O
and	O
Musashi	O
-	I:C0536620
1	I:C0536620
were	O
significantly	O
increased	O
in	O
the	O
hPDSC	O
treatment	B:C0087111
group	O
.	O

Both	O
preventive	O
and	O
therapeutic	B:C0087111
efficacies	O
of	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
were	O
noted	O
against	O
IR	O
-	I:C0341275
induced	I:C0341275
enteropathy	I:C0341275
.	O

Both	O
preventive	O
and	O
therapeutic	O
efficacies	O
of	O
human	B:C1257975
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
were	O
noted	O
against	O
IR	O
-	I:C0341275
induced	I:C0341275
enteropathy	I:C0341275
.	O

Both	O
preventive	O
and	O
therapeutic	O
efficacies	O
of	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
were	O
noted	O
against	O
IR	B:C0341275
-	I:C0341275
induced	I:C0341275
enteropathy	I:C0341275
.	O

Label	O
-	O
free	O
quantification	O
was	O
used	O
to	O
identify	O
biomarkers	B:C0005516
which	O
predict	O
favorable	O
responses	I:C4054987
after	O
hPDSC	O
treatment	O
,	O
and	O
finally	O
glutathione	O
S	I:C3814418
-	I:C3814418
transferase	I:C3814418
-	I:C3814418
mu	I:C3814418
type	O
,	O
interleukin	O
-	I:C0085295
10	I:C0085295
,	O
and	O
peroxired	O
oxin	I:C1137156
-	I:C1137156
2	I:C1137156
were	O
validated	O
as	O
proteomic	O
biomarkers	O
predicting	O
a	O
favorable	O
response	I:C4054987
to	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
in	O
radiation	O
enteropathy	I:C0341275
.	O

Label	O
-	O
free	O
quantification	O
was	O
used	O
to	O
identify	O
biomarkers	O
which	O
predict	O
favorable	B:C4054987
responses	I:C4054987
after	O
hPDSC	O
treatment	O
,	O
and	O
finally	O
glutathione	O
S	I:C3814418
-	I:C3814418
transferase	I:C3814418
-	I:C3814418
mu	I:C3814418
type	O
,	O
interleukin	O
-	I:C0085295
10	I:C0085295
,	O
and	O
peroxired	O
oxin	I:C1137156
-	I:C1137156
2	I:C1137156
were	O
validated	O
as	O
proteomic	O
biomarkers	O
predicting	O
a	O
favorable	O
response	I:C4054987
to	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
in	O
radiation	O
enteropathy	I:C0341275
.	O

Label	O
-	O
free	O
quantification	O
was	O
used	O
to	O
identify	O
biomarkers	O
which	O
predict	O
favorable	O
responses	I:C4054987
after	O
hPDSC	B:C1257975
treatment	O
,	O
and	O
finally	O
glutathione	O
S	I:C3814418
-	I:C3814418
transferase	I:C3814418
-	I:C3814418
mu	I:C3814418
type	O
,	O
interleukin	O
-	I:C0085295
10	I:C0085295
,	O
and	O
peroxired	O
oxin	I:C1137156
-	I:C1137156
2	I:C1137156
were	O
validated	O
as	O
proteomic	O
biomarkers	O
predicting	O
a	O
favorable	O
response	I:C4054987
to	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
in	O
radiation	O
enteropathy	I:C0341275
.	O

Label	O
-	O
free	O
quantification	O
was	O
used	O
to	O
identify	O
biomarkers	O
which	O
predict	O
favorable	O
responses	I:C4054987
after	O
hPDSC	O
treatment	B:C0087111
,	O
and	O
finally	O
glutathione	O
S	I:C3814418
-	I:C3814418
transferase	I:C3814418
-	I:C3814418
mu	I:C3814418
type	O
,	O
interleukin	O
-	I:C0085295
10	I:C0085295
,	O
and	O
peroxired	O
oxin	I:C1137156
-	I:C1137156
2	I:C1137156
were	O
validated	O
as	O
proteomic	O
biomarkers	O
predicting	O
a	O
favorable	O
response	I:C4054987
to	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
in	O
radiation	O
enteropathy	I:C0341275
.	O

Label	O
-	O
free	O
quantification	O
was	O
used	O
to	O
identify	O
biomarkers	O
which	O
predict	O
favorable	O
responses	I:C4054987
after	O
hPDSC	O
treatment	O
,	O
and	O
finally	O
glutathione	B:C3814418
S	I:C3814418
-	I:C3814418
transferase	I:C3814418
-	I:C3814418
mu	I:C3814418
type	O
,	O
interleukin	O
-	I:C0085295
10	I:C0085295
,	O
and	O
peroxired	O
oxin	I:C1137156
-	I:C1137156
2	I:C1137156
were	O
validated	O
as	O
proteomic	O
biomarkers	O
predicting	O
a	O
favorable	O
response	I:C4054987
to	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
in	O
radiation	O
enteropathy	I:C0341275
.	O

Label	O
-	O
free	O
quantification	O
was	O
used	O
to	O
identify	O
biomarkers	O
which	O
predict	O
favorable	O
responses	I:C4054987
after	O
hPDSC	O
treatment	O
,	O
and	O
finally	O
glutathione	O
S	I:C3814418
-	I:C3814418
transferase	I:C3814418
-	I:C3814418
mu	I:C3814418
type	O
,	O
interleukin	B:C0085295
-	I:C0085295
10	I:C0085295
,	O
and	O
peroxired	O
oxin	I:C1137156
-	I:C1137156
2	I:C1137156
were	O
validated	O
as	O
proteomic	O
biomarkers	O
predicting	O
a	O
favorable	O
response	I:C4054987
to	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
in	O
radiation	O
enteropathy	I:C0341275
.	O

Label	O
-	O
free	O
quantification	O
was	O
used	O
to	O
identify	O
biomarkers	O
which	O
predict	O
favorable	O
responses	I:C4054987
after	O
hPDSC	O
treatment	O
,	O
and	O
finally	O
glutathione	O
S	I:C3814418
-	I:C3814418
transferase	I:C3814418
-	I:C3814418
mu	I:C3814418
type	O
,	O
interleukin	O
-	I:C0085295
10	I:C0085295
,	O
and	O
peroxired	B:C1137156
oxin	I:C1137156
-	I:C1137156
2	I:C1137156
were	O
validated	O
as	O
proteomic	O
biomarkers	O
predicting	O
a	O
favorable	O
response	I:C4054987
to	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
in	O
radiation	O
enteropathy	I:C0341275
.	O

Label	O
-	O
free	O
quantification	O
was	O
used	O
to	O
identify	O
biomarkers	O
which	O
predict	O
favorable	O
responses	I:C4054987
after	O
hPDSC	O
treatment	O
,	O
and	O
finally	O
glutathione	O
S	I:C3814418
-	I:C3814418
transferase	I:C3814418
-	I:C3814418
mu	I:C3814418
type	O
,	O
interleukin	O
-	I:C0085295
10	I:C0085295
,	O
and	O
peroxired	O
oxin	I:C1137156
-	I:C1137156
2	I:C1137156
were	O
validated	O
as	O
proteomic	B:C0751973
biomarkers	O
predicting	O
a	O
favorable	O
response	I:C4054987
to	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
in	O
radiation	O
enteropathy	I:C0341275
.	O

Label	O
-	O
free	O
quantification	O
was	O
used	O
to	O
identify	O
biomarkers	O
which	O
predict	O
favorable	O
responses	I:C4054987
after	O
hPDSC	O
treatment	O
,	O
and	O
finally	O
glutathione	O
S	I:C3814418
-	I:C3814418
transferase	I:C3814418
-	I:C3814418
mu	I:C3814418
type	O
,	O
interleukin	O
-	I:C0085295
10	I:C0085295
,	O
and	O
peroxired	O
oxin	I:C1137156
-	I:C1137156
2	I:C1137156
were	O
validated	O
as	O
proteomic	O
biomarkers	B:C0005516
predicting	O
a	O
favorable	O
response	I:C4054987
to	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
in	O
radiation	O
enteropathy	I:C0341275
.	O

Label	O
-	O
free	O
quantification	O
was	O
used	O
to	O
identify	O
biomarkers	O
which	O
predict	O
favorable	O
responses	I:C4054987
after	O
hPDSC	O
treatment	O
,	O
and	O
finally	O
glutathione	O
S	I:C3814418
-	I:C3814418
transferase	I:C3814418
-	I:C3814418
mu	I:C3814418
type	O
,	O
interleukin	O
-	I:C0085295
10	I:C0085295
,	O
and	O
peroxired	O
oxin	I:C1137156
-	I:C1137156
2	I:C1137156
were	O
validated	O
as	O
proteomic	O
biomarkers	O
predicting	O
a	O
favorable	B:C4054987
response	I:C4054987
to	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
in	O
radiation	O
enteropathy	I:C0341275
.	O

Label	O
-	O
free	O
quantification	O
was	O
used	O
to	O
identify	O
biomarkers	O
which	O
predict	O
favorable	O
responses	I:C4054987
after	O
hPDSC	O
treatment	O
,	O
and	O
finally	O
glutathione	O
S	I:C3814418
-	I:C3814418
transferase	I:C3814418
-	I:C3814418
mu	I:C3814418
type	O
,	O
interleukin	O
-	I:C0085295
10	I:C0085295
,	O
and	O
peroxired	O
oxin	I:C1137156
-	I:C1137156
2	I:C1137156
were	O
validated	O
as	O
proteomic	O
biomarkers	O
predicting	O
a	O
favorable	O
response	I:C4054987
to	O
human	B:C1257975
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
in	O
radiation	O
enteropathy	I:C0341275
.	O

Label	O
-	O
free	O
quantification	O
was	O
used	O
to	O
identify	O
biomarkers	O
which	O
predict	O
favorable	O
responses	I:C4054987
after	O
hPDSC	O
treatment	O
,	O
and	O
finally	O
glutathione	O
S	I:C3814418
-	I:C3814418
transferase	I:C3814418
-	I:C3814418
mu	I:C3814418
type	O
,	O
interleukin	O
-	I:C0085295
10	I:C0085295
,	O
and	O
peroxired	O
oxin	I:C1137156
-	I:C1137156
2	I:C1137156
were	O
validated	O
as	O
proteomic	O
biomarkers	O
predicting	O
a	O
favorable	O
response	I:C4054987
to	O
human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
in	O
radiation	B:C0341275
enteropathy	I:C0341275
.	O

human	B:C1257975
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
may	O
be	O
a	O
useful	O
prophylactic	O
and	O
therapeutic	O
cell	O
therapy	I:C0302189
for	O
radiation	O
enteropathy	I:C0341275
.	O

human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
may	O
be	O
a	O
useful	O
prophylactic	B:C0199176
and	O
therapeutic	O
cell	O
therapy	I:C0302189
for	O
radiation	O
enteropathy	I:C0341275
.	O

human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
may	O
be	O
a	O
useful	O
prophylactic	O
and	O
therapeutic	B:C0087111
cell	O
therapy	I:C0302189
for	O
radiation	O
enteropathy	I:C0341275
.	O

human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
may	O
be	O
a	O
useful	O
prophylactic	O
and	O
therapeutic	O
cell	B:C0302189
therapy	I:C0302189
for	O
radiation	O
enteropathy	I:C0341275
.	O

human	O
placenta	I:C1257975
-	I:C1257975
derived	I:C1257975
mesenchymal	I:C1257975
stem	I:C1257975
cells	I:C1257975
may	O
be	O
a	O
useful	O
prophylactic	O
and	O
therapeutic	O
cell	O
therapy	I:C0302189
for	O
radiation	B:C0341275
enteropathy	I:C0341275
.	O

